サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1697961

精神科デジタルバイオマーカーの世界市場：市場規模・シェア・動向、業界分析 (種類別・診療行為別・最終用途別・地域別)、将来予測 (2025年～2034年)

Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type, Clinical Practice, End Use, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
精神科デジタルバイオマーカーの世界市場：市場規模・シェア・動向、業界分析 (種類別・診療行為別・最終用途別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年03月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の精神科デジタルバイオマーカー市場規模は2034年までに55億4,377万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

精神科デジタルバイオマーカーは、精神衛生状態を評価するためにデジタル機器を通じて収集される客観的で定量化可能な生理学的および行動学的データポイントです。精神科デジタルバイオマーカー市場は、人工知能、ウェアラブルヘルス技術、モバイルベースのメンタルヘルスモニタリングの進歩に牽引され、大きな拡大を経験しています。うつ病、統合失調症、不安障害などの精神疾患の有病率の増加が精神科デジタルバイオマーカー市場の需要を促進しており、臨床医や研究者は正確な診断と治療の個別化のためにデータ駆動型のリアルタイムモニタリングツールを求めています。さらに、スマートウォッチ、モバイルアプリ、AIを活用した分析へのバイオセンサーの統合が進み、患者の遠隔モニタリングや臨床的意思決定が強化されていることも、市場の成長を後押ししています。

精神科デジタルバイオマーカー業界の動向は、機械学習アルゴリズムを活用して行動パターン、音声バイオマーカー、生理的信号を分析し、予測精度と早期介入能力を向上させる方向へのシフトを示しています。さらに、製薬企業やバイオテクノロジー企業は、デジタルバイオマーカーを臨床試験に組み込み、患者募集や治療効果評価を最適化することで、精神科デジタルバイオマーカー市場の拡大を促進しています。また、利害関係者がデータプライバシーとセキュリティの枠組みの遵守を重視していることから、規制の進展とデジタルヘルス技術への投資の増加も市場のダイナミクスを後押ししています。

精神科デジタルバイオマーカー市場のビジネスチャンスは、デジタルバイオマーカーを使用して個々の患者データに基づいて治療戦略を調整する精密精神医学の開発にあります。遠隔医療やバーチャル・メンタルヘルスサービスの導入が進むことで、医療提供者がデジタル・モニタリング・ソリューションを遠隔治療モデルに統合することも市場機会のひとつとなります。デジタルバイオマーカーが規制状況に受け入れられ、償還の枠組みが進化するにつれて、マルチモーダルデータ統合とAI主導のメンタルヘルス分析における継続的な技術革新が精神科医療の将来の展望を形成し、市場は力強い成長を遂げると予想されます。

精神科デジタルバイオマーカー市場：分析概要

種類別では、スマートウォッチ、フィットネストラッカー、継続的なメンタルヘルスモニタリングのためのウェアラブルEEGデバイスに高度なバイオセンサーが統合されつつあることから、ウェアラブルセグメントが2024年の精神科デジタルバイオマーカー市場シェアを独占しました。

最終用途に基づくと、早期診断のための精神科デジタルバイオマーカー採用の増加により、医療企業セグメントが2024年に最大の市場シェアを占めました。

2024年には、北米が精神科デジタルバイオマーカー市場で最大の収益シェアを占めましたが、これは同地域の医療インフラが先進的であるためです。

欧州市場は、メンタルヘルス研究を支援する政府の取り組みにより、予測期間中に最も高いCAGRを記録する見込みです。

世界の主要企業の一例としては、Biogen社、Brainomix社、Clario社、Empatica社、Huma社、IXICO plc社、Koneksa Health社、PureTech Health PLC社、Sonde Health社、VivoSense社などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の精神科デジタルバイオマーカー市場の洞察

  • 市場スナップショット
  • 精神科デジタルバイオマーカーの市場力学
    • 促進要因と機会
      • 精神疾患の有病率の上昇
      • ウェアラブル・モバイルヘルス技術の進歩
    • 抑制要因と課題
      • データプライバシーに関する懸念
  • PESTLE分析
  • 精神科デジタルバイオマーカー市場の動向
  • バリューチェーン分析

第5章 世界の精神科デジタルバイオマーカー市場：種類別

  • 主な分析結果
  • イントロダクション
  • ウェアラブル
  • モバイルベースのアプリケーション
  • センサー
  • その他

第6章 世界の精神科デジタルバイオマーカー市場：診療行為別

  • 主な分析結果
  • イントロダクション
  • 診断用精神科デジタルバイオマーカー
  • モニタリング用精神科デジタルバイオマーカー
  • 予測・予後用精神科デジタルバイオマーカー
  • その他

第7章 世界の精神科デジタルバイオマーカー市場：最終用途別

  • 主な分析結果
  • イントロダクション
  • 医療企業
  • 医療提供者
  • 支払者
  • その他

第8章 世界の精神科デジタルバイオマーカー市場：地域別

  • 主な分析結果
  • イントロダクション
    • 精神科デジタルバイオマーカー市場の分析：地域別 (2020～2034年)
  • 北米
    • 北米：種類別（2020～2034年）
    • 北米：診療行為別（2020～2034年）
    • 北米：最終用途別（2020～2034年）
    • 米国
    • カナダ
  • 欧州
    • 欧州：種類別（2020～2034年）
    • 欧州：診療行為別（2020～2034年）
    • 欧州：最終用途別（2020～2034年）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：種類別（2020～2034年）
    • アジア太平洋：診療行為別（2020～2034年）
    • アジア太平洋：最終用途別（2020～2034年）
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：種類別（2020～2034年）
    • 中東・アフリカ：診療行為別（2020～2034年）
    • 中東・アフリカ：最終用途別（2020～2034年）
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：種類別（2020～2034年）
    • ラテンアメリカ：診療行為別（2020～2034年）
    • ラテンアメリカ：最終用途別（2020～2034年）
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Biogen
  • Brainomix
  • Clario
  • Empatica Inc.
  • Huma
  • IXICO plc
  • Koneksa Health
  • PureTech Health PLC
  • Sonde Health, Inc.
  • VivoSense
  • Xiamen AJK Technology Co., Ltd.
図表

List of Tables:

  • Table 1 Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 3 Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 4 North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 6 North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 7 US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 8 US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 9 US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 10 Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 12 Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 15 Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 16 UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 18 UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 19 France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 21 France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 22 Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 24 Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 27 Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 28 Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 30 Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 31 Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 33 Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 34 Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 36 Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 43 China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 45 China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 46 India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 48 India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 51 Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 52 Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 54 Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 57 Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 58 South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 60 South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 63 Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 73 UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 75 UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 76 Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 78 Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 79 South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 81 South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 87 Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 88 Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 90 Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 91 Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 93 Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 94 Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 96 Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Psychiatric Digital Biomarkers Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Psychiatric Digital Biomarkers Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Clinical Practice
  • Figure 9. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2024 & 2034 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global Psychiatric Digital Biomarkers Market, by End Use, 2024 & 2034 (USD Million)
目次
Product Code: PM5446

The global psychiatric digital biomarkers market size is expected to reach USD 5,543.77 million by 2034, according to a new study by Polaris Market Research. The report "Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type (Wearable, Mobile-Based Applications, Sensors, and Others), Clinical Practice, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Psychiatric digital biomarkers are objective, quantifiable physiological and behavioral data points collected through digital devices to assess mental health conditions. The psychiatric digital biomarkers market is experiencing significant expansion, driven by advancements in artificial intelligence, wearable health technologies, and mobile-based mental health monitoring. The growing prevalence of psychiatric disorders, including depression, schizophrenia, and anxiety, is fueling psychiatric digital biomarkers market demand, as clinicians and researchers seek data-driven, real-time monitoring tools for accurate diagnosis and treatment personalization. The market growth is further supported by the increasing integration of biosensors in smartwatches, mobile apps, and AI-powered analytics, which enhance remote patient monitoring and clinical decision-making.

The psychiatric digital biomarkers industry trends indicate a shift toward leveraging machine learning algorithms to analyze behavioral patterns, voice biomarkers, and physiological signals, improving predictive accuracy and early intervention capabilities. Additionally, pharmaceutical and biotech companies are incorporating digital biomarkers into clinical trials, optimizing patient recruitment and therapeutic efficacy assessments, thereby driving psychiatric digital biomarkers market expansion. Regulatory advancements and increasing investments in digital health technologies are also encouraging market dynamics as stakeholders focus on ensuring compliance with data privacy and security frameworks.

The psychiatric digital biomarkers market opportunities lie in the development of precision psychiatry, where digital biomarkers are used to tailor treatment strategies based on individual patient data. The increasing adoption of telemedicine and virtual mental health services presents another market opportunity; as healthcare providers integrate digital monitoring solutions into remote care models. As digital biomarkers gain regulatory acceptance and reimbursement frameworks evolve, the market is expected to witness robust growth, with continuous innovation in multimodal data integration and AI-driven mental health analytics shaping the future landscape of psychiatric care.

Psychiatric Digital Biomarkers Market Report Highlights

In terms of type, the wearable segment dominated the psychiatric digital biomarkers market share in 2024, due to the growing integration of advanced biosensors in smartwatches, fitness trackers, and wearable EEG devices for continuous mental health monitoring.

Based on end use, the healthcare companies segment accounted for the largest market share in 2024 due to the increasing adoption of psychiatric digital biomarkers for early diagnosis.

In 2024, North America accounted for the largest share of the psychiatric digital biomarkers market revenue due to the region's advanced healthcare infrastructure.

The Europe market is expected to register the highest CAGR during the forecast period due to government initiatives supporting mental health research.

A few of the global key market players are Biogen; Brainomix; Clario; Empatica Inc.; Huma; IXICO plc; Koneksa Health; PureTech Health PLC; Sonde Health, Inc.; and VivoSense.

Polaris Market Research has segmented the psychiatric digital biomarkers market report on the basis of type, clinical practice, end use, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Wearable
  • Mobile-Based Applications
  • Sensors
  • Others

By Clinical Practice Outlook (Revenue - USD Million, 2020-2034)

  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Psychiatric Digital Biomarkers Market Insights

  • 4.1. Psychiatric Digital Biomarkers Market - Market Snapshot
  • 4.2. Psychiatric Digital Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Mental Health Disorders
      • 4.2.1.2. Wearable and Mobile Health Technology Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Psychiatric Digital Biomarkers Market Trends
  • 4.6. Value Chain Analysis

5. Global Psychiatric Digital Biomarkers Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • 5.3. Wearable
    • 5.3.1. Global Psychiatric Digital Biomarkers Market, by Wearable, by Region, 2020-2034 (USD Million)
  • 5.4. Mobile based Applications
    • 5.4.1. Global Psychiatric Digital Biomarkers Market, Mobile based Applications, by Region, 2020-2034 (USD Million)
  • 5.5. Sensors
    • 5.5.1. Global Psychiatric Digital Biomarkers Market, by Sensors, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Psychiatric Digital Biomarkers Market, by Clinical Practice

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • 6.3. Diagnostic Psychiatric Digital Biomarkers
    • 6.3.1. Global Psychiatric Digital Biomarkers Market, by Diagnostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.4. Monitoring Psychiatric Digital Biomarkers
    • 6.4.1. Global Psychiatric Digital Biomarkers Market, by Monitoring Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.5. Predictive and Prognostic Psychiatric Digital Biomarkers
    • 6.5.1. Global Psychiatric Digital Biomarkers Market, by Predictive and Prognostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Psychiatric Digital Biomarkers Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Healthcare companies
    • 7.3.1. Global Psychiatric Digital Biomarkers Market, by Healthcare companies, by Region, 2020-2034 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Global Psychiatric Digital Biomarkers Market, by Healthcare Providers, by Region, 2020-2034 (USD Million)
  • 7.5. Payers
    • 7.5.1. Global Psychiatric Digital Biomarkers Market, by Payers, by Region, 2020-2034 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Psychiatric Digital Biomarkers Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Psychiatric Digital Biomarkers Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Psychiatric Digital Biomarkers Market - North America
    • 8.3.1. North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.3.3. North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Psychiatric Digital Biomarkers Market - US
      • 8.3.4.1. US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.3.4.3. US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Psychiatric Digital Biomarkers Market - Canada
      • 8.3.5.1. Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Psychiatric Digital Biomarkers Market - Europe
    • 8.4.1. Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.4.3. Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Psychiatric Digital Biomarkers Market - UK
      • 8.4.4.1. UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Psychiatric Digital Biomarkers Market - France
      • 8.4.5.1. France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.5.3. France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Psychiatric Digital Biomarkers Market - Germany
      • 8.4.6.1. Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Psychiatric Digital Biomarkers Market - Italy
      • 8.4.7.1. Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Psychiatric Digital Biomarkers Market - Spain
      • 8.4.8.1. Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Psychiatric Digital Biomarkers Market - Netherlands
      • 8.4.9.1. Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Psychiatric Digital Biomarkers Market - Russia
      • 8.4.10.1. Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Psychiatric Digital Biomarkers Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Psychiatric Digital Biomarkers Market - Asia Pacific
    • 8.5.1. Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Psychiatric Digital Biomarkers Market - China
      • 8.5.4.1. China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.4.3. China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Psychiatric Digital Biomarkers Market - India
      • 8.5.5.1. India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.5.3. India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Psychiatric Digital Biomarkers Market - Malaysia
      • 8.5.6.1. Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Psychiatric Digital Biomarkers Market - Japan
      • 8.5.7.1. Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Psychiatric Digital Biomarkers Market - Indonesia
      • 8.5.8.1. Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Psychiatric Digital Biomarkers Market - South Korea
      • 8.5.9.1. South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Psychiatric Digital Biomarkers Market - Australia
      • 8.5.10.1. Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Psychiatric Digital Biomarkers Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Psychiatric Digital Biomarkers Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Psychiatric Digital Biomarkers Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Psychiatric Digital Biomarkers Market - UAE
      • 8.6.5.1. UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Psychiatric Digital Biomarkers Market - Israel
      • 8.6.6.1. Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Psychiatric Digital Biomarkers Market - South Africa
      • 8.6.7.1. South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Psychiatric Digital Biomarkers Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Psychiatric Digital Biomarkers Market - Latin America
    • 8.7.1. Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Psychiatric Digital Biomarkers Market - Mexico
      • 8.7.4.1. Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Psychiatric Digital Biomarkers Market - Brazil
      • 8.7.5.1. Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Psychiatric Digital Biomarkers Market - Argentina
      • 8.7.6.1. Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Psychiatric Digital Biomarkers Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Brainomix
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clario
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Empatica Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Huma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. IXICO plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Koneksa Health
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. PureTech Health PLC
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sonde Health, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. VivoSense
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Xiamen AJK Technology Co., Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development